Pivotal ATHENA Study Validates Roche Cobas HPV Test
ATHENA study shows the test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70% of cervical cancer.
Read MoreATHENA study shows the test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70% of cervical cancer.
Read MoreThe RNAscope test under development demonstrated 16% higher detection sensitivity than the HPV DNA test used in the study.
Read MoreBiOasis announces completion of a project intended to produce proprietary monoclonal antibodies for its Cognitest blood test for Alzheimer’s disease.
Read MoreACT Biotech submits Special Protocol Assessment with FDA for Phase 3 trial of telatinib for front-line treatment of stomach cancer.
Read MoreAmerican Academy of Pediatricians lauds decision it says safeguards the nation’s vaccine supply.
Read More